Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Use of capsule endoscopy in inflammatory bowel disease in clinical practice in Spain. Results from a national survey
Alfonso Elosua González; Óscar Nantes Castillejo; Ignacio Fernández-Urién Sainz; Alicia López-García; Óscar Murcia Pomares; Yamile Zabana;
Gastroenterol Hepatol. 2021;44:696-703
Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease
Francisco Guilherme Cancela Penna; Rodrigo Macedo Rosa; Fernando H. Pereira; Pedro Ferrari Sales Cunha; Stella Cristina S. Sousa; Teresa Cristina A. Ferrari; Carlos Cara; Maria de Lourdes A. Ferrari;
Gastroenterol Hepatol. 2021;44:87-95
Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study
Ignacio Marín-Jiménez; Manuel Barreiro-de Acosta; María Esteve; Luisa Castro-Laria; Santiago García-López; Daniel Ceballos; Ana Echarri; María Dolores Martín-Arranz; David Busquets; Jordina Llaó; Mercè Navarro-Llavat; José María Huguet; Federico Argüelles-Arias; Raquel Vicente; José Miguel Boudet; Gema Díaz; Ana M. Sánchez-Migallón; Francesc Casellas;
Gastroenterol Hepatol. 2022;45:165-76